Jane Street’s Vanda Pharmaceuticals VNDA Stock Holding History

Jane Street’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$258K	Sell	37,400 -47,400	-56%	-$366K	﹤0.01%	9564
2025 Q4	$748K	Buy	+84,800	New	+$467K	﹤0.01%	6791
2025 Q2	–	Sell	-13,300	Closed	-$61K	–	11017
2025 Q1	$61K	Buy	+13,300	New	+$62K	﹤0.01%	8957
2024 Q4	–	Sell	-15,200	Closed	-$71.3K	–	10693
2024 Q3	$71.3K	Buy	+15,200	New	+$81.5K	﹤0.01%	9096
2023 Q1	–	Sell	-13,200	Closed	-$97.5K	–	10006
2022 Q4	$97.5K	Buy	+13,200	New	+$129K	﹤0.01%	8109
2022 Q2	–	Sell	-11,400	Closed	-$129K	–	10992
2022 Q1	$129K	Sell	11,400 -6,300	-36%	-$82.8K	﹤0.01%	9325
2021 Q4	$278K	Buy	17,700 +6,800	+62%	+$118K	﹤0.01%	8320
2021 Q3	$187K	Sell	10,900 -13,600	-56%	-$238K	﹤0.01%	8897
2021 Q2	$527K	Buy	+24,500	New	+$438K	﹤0.01%	7138
2015 Q3	–	Sell	-10,700	Closed	-$136K	–	4202
2015 Q2	$136K	Buy	+10,700	New	+$115K	﹤0.01%	3361

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's VNDA Position: Q1 2026 in Review

Jane Street increased its Vanda Pharmaceuticals (VNDA) stake by 324% in Q1 2026, buying an estimated $1.24M and bringing the position to 210,243 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #5707.

Jane Street first reported a position in VNDA in Q1 2014 and has held it in 26 quarters since. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Jane Street held 210,243 shares of Vanda Pharmaceuticals worth $1.45M as of Q1 2026.
Jane Street bought 160,602 Vanda Pharmaceuticals shares in Q1 2026, an estimated $1.24M.
Vanda Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5707 holding.
Jane Street first reported a position in Vanda Pharmaceuticals in Q1 2014 and has held it in 26 quarters since.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.